{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T19:30:35Z","timestamp":1793820635796,"version":"4.6.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["24K11926"],"award-info":[{"award-number":["24K11926"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsurgicalresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Surgical Research"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jss.2026.07.053","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:37:31Z","timestamp":1787618251000},"page":"985-995","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["RAD51 Predicts Poor Prognosis and Serves as a Therapeutic Target in Intrahepatic Cholangiocarcinoma"],"prefix":"10.1016","volume":"326","author":[{"given":"Koya","family":"Fujii","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4403-8313","authenticated-orcid":false,"given":"Takanori","family":"Konishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsukasa","family":"Takayashiki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigetsugu","family":"Takano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nozomu","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isamu","family":"Hosokawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Mishima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoe","family":"Nishino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kensuke","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichiro","family":"Nakada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Ohtsuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jss.2026.07.053_bib1","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","article-title":"Cholangiocarcinoma 2020: the next horizon in mechanisms and management","volume":"17","author":"Banales","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jss.2026.07.053_bib2","first-page":"198","article-title":"Advances in the treatment of intrahepatic cholangiocarcinoma: an overview of the current and future therapeutic landscape for clinicians","volume":"73","author":"Moris","year":"2023","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jss.2026.07.053_bib3","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/jhbp.1038","article-title":"Impact of lymph node dissection on clinical outcomes of intrahepatic cholangiocarcinoma: inverse probability of treatment weighting with survival analysis","volume":"29","author":"Umeda","year":"2022","journal-title":"J Hepatobiliary Pancreat Sci"},{"issue":"Suppl 3","key":"10.1016\/j.jss.2026.07.053_bib4","doi-asserted-by":"crossref","first-page":"S1093","DOI":"10.1245\/s10434-015-4768-9","article-title":"Downsizing chemotherapy for initially unresectable locally advanced biliary tract cancer patients treated with gemcitabine plus cisplatin combination therapy followed by radical surgery","volume":"22","author":"Kato","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jss.2026.07.053_bib5","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","article-title":"Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer","volume":"362","author":"Valle","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jss.2026.07.053_bib6","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2200015","article-title":"Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer","volume":"1","author":"Oh","year":"2022","journal-title":"NEJM Evid"},{"key":"10.1016\/j.jss.2026.07.053_bib7","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/jhbp.1219","article-title":"Randomized phase III study of gemcitabine, cisplatin plus S-1 versus gemcitabine, cisplatin for advanced biliary tract cancer (KHBO1401- MITSUBA)","volume":"30","author":"Ioka","year":"2023","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"10.1016\/j.jss.2026.07.053_bib8","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.3390\/cells11091463","article-title":"DNA damage response inhibitors in cholangiocarcinoma: current progress and perspectives","volume":"11","author":"Gonul Geyik","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.jss.2026.07.053_bib9","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ctrv.2018.09.002","article-title":"Biliary tract cancer: state of the art and potential role of DNA damage repair","volume":"70","author":"Lamarca","year":"2018","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.jss.2026.07.053_bib10","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3390\/jpm11040245","article-title":"Germline mutations in other homologous recombination repair-related genes than BRCA1\/2: predictive or prognostic factors?","volume":"11","author":"Cortesi","year":"2021","journal-title":"J Pers Med"},{"key":"10.1016\/j.jss.2026.07.053_bib11","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejca.2016.03.005","article-title":"Homologous recombination deficiency and ovarian cancer","volume":"60","author":"Ledermann","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jss.2026.07.053_bib12","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1002\/ijc.33230","article-title":"Comprehensive genomic landscape and precision therapeutic approach in biliary tract cancers","volume":"148","author":"Okamura","year":"2021","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jss.2026.07.053_bib13","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ejca.2019.07.022","article-title":"Therapeutic relevance of targeted sequencing in management of patients with advanced biliary tract cancer: DNA damage repair gene mutations as a predictive biomarker","volume":"120","author":"Chae","year":"2019","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jss.2026.07.053_bib14","doi-asserted-by":"crossref","first-page":"4701","DOI":"10.1158\/1078-0432.CCR-19-0127","article-title":"Alterations in DNA damage repair genes in primary liver cancer","volume":"25","author":"Lin","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jss.2026.07.053_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/PO.17.00286","article-title":"Prevalence of homologous recombination-related gene mutations across multiple cancer types","volume":"2","author":"Heeke","year":"2018","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.jss.2026.07.053_bib16","article-title":"The emerging roles of Rad51 in cancer and its potential as a therapeutic target","volume":"12","author":"Wang","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.jss.2026.07.053_bib17","article-title":"A pan-cancer bioinformatic analysis of RAD51 regarding the values for diagnosis, prognosis, and therapeutic prediction","volume":"12","author":"Liu","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.jss.2026.07.053_bib18","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/s12935-021-01953-5","article-title":"Predictive value of RAD51 on the survival and drug responsiveness of ovarian cancer","volume":"21","author":"Feng","year":"2021","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.jss.2026.07.053_bib19","doi-asserted-by":"crossref","first-page":"5358","DOI":"10.3390\/cancers13215358","article-title":"Expression levels of RAD51 inversely correlate with survival of glioblastoma patients","volume":"13","author":"Morrison","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jss.2026.07.053_bib20","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1186\/s12935-019-1077-6","article-title":"RAD51 is a potential marker for prognosis and regulates cell proliferation in pancreatic cancer","volume":"19","author":"Zhang","year":"2019","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.jss.2026.07.053_bib21","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.lungcan.2017.01.009","article-title":"Prognostic and predictive value of loss of nuclear RAD51 immunoreactivity in resected non-small cell lung cancer patients","volume":"105","author":"Gachechiladze","year":"2017","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jss.2026.07.053_bib22","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.radonc.2007.06.012","article-title":"The BRCA1\/BRCA2\/Rad51 complex is a prognostic and predictive factor in early breast cancer","volume":"84","author":"Soderlund","year":"2007","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.jss.2026.07.053_bib23","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1667\/RR1910.1","article-title":"Homologous recombination contributes to the repair of DNA double-strand breaks induced by high-energy iron ions","volume":"173","author":"Zafar","year":"2010","journal-title":"Radiat Res"},{"key":"10.1016\/j.jss.2026.07.053_bib24","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202013366","article-title":"Quantitative imaging of RAD51 expression as a marker of platinum resistance in ovarian cancer","volume":"13","author":"Hoppe","year":"2021","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.jss.2026.07.053_bib25","doi-asserted-by":"crossref","first-page":"7023","DOI":"10.1245\/s10434-026-19729-4","article-title":"Neoadjuvant therapy as a selection strategy for curative resection in high-risk intrahepatic cholangiocarcinoma","volume":"33","author":"Dong","year":"2026","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jss.2026.07.053_bib26","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/hpb.12333","article-title":"Model to predict survival after surgical resection of intrahepatic cholangiocarcinoma: the Mayo clinic experience","volume":"17","author":"Ali","year":"2015","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.jss.2026.07.053_bib27","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/emmm.201201760","article-title":"A novel small molecule RAD51 inactivator overcomes imatinib-resistance in chronic myeloid leukaemia","volume":"5","author":"Zhu","year":"2013","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.jss.2026.07.053_bib28","first-page":"184","article-title":"Inflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiocarcinoma cells by a nitric oxide-dependent mechanism","volume":"60","author":"Jaiswal","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.jss.2026.07.053_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2021.188597","article-title":"Inhibiting homologous recombination by targeting RAD51 protein","volume":"1876","author":"Demeyer","year":"2021","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"10.1016\/j.jss.2026.07.053_bib30","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.3390\/cancers13122930","article-title":"Regulation of RAD51 at the transcriptional and functional levels: what prospects for cancer therapy?","volume":"13","author":"Orhan","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jss.2026.07.053_bib31","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jhep.2022.09.025","article-title":"Hereditary cancer variants and homologous recombination deficiency in biliary tract cancer","volume":"78","author":"Okawa","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.jss.2026.07.053_bib32","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.18632\/oncotarget.1923","article-title":"Rad51 supports triple negative breast cancer metastasis","volume":"5","author":"Wiegmans","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.jss.2026.07.053_bib33","article-title":"Utility of homologous recombination deficiency biomarkers across cancer types","volume":"6","author":"Takamatsu","year":"2022","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.jss.2026.07.053_bib34","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1158\/1078-0432.CCR-20-0418","article-title":"Genomic methods identify homologous recombination deficiency in pancreas adenocarcinoma and optimize treatment selection","volume":"26","author":"Park","year":"2020","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jss.2026.07.053_bib35","doi-asserted-by":"crossref","first-page":"3764","DOI":"10.1158\/1078-0432.CCR-15-2477","article-title":"Homologous recombination deficiency (HRD) score predicts response to platinum-containing neoadjuvant chemotherapy in patients with triple-negative breast cancer","volume":"22","author":"Telli","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jss.2026.07.053_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2024.103630","article-title":"Understanding homologous recombination repair deficiency in biliary tract cancers: clinical implications and correlation with platinum sensitivity","volume":"9","author":"Mavroeidi","year":"2024","journal-title":"ESMO Open"},{"key":"10.1016\/j.jss.2026.07.053_bib37","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1245\/s10434-013-3220-2","article-title":"Rad51 expression is a useful predictive factor for the efficacy of neoadjuvant chemoradiotherapy in squamous cell carcinoma of the esophagus","volume":"21","author":"Nakanoko","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jss.2026.07.053_bib38","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1097\/SLA.0000000000003975","article-title":"RAD51 expression as a biomarker to predict efficacy of preoperative therapy and survival for esophageal squamous cell carcinoma: a large-cohort observational study (KSCC1307)","volume":"275","author":"Saeki","year":"2022","journal-title":"Ann Surg"},{"key":"10.1016\/j.jss.2026.07.053_bib39","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1158\/1078-0432.CCR-22-2551","article-title":"Human metastatic cholangiocarcinoma patient-derived xenografts and tumoroids for preclinical drug evaluation","volume":"29","author":"Serra-Camprubi","year":"2023","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jss.2026.07.053_bib40","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1158\/2159-8290.CD-24-1383","article-title":"Generation of a biliary tract cancer cell line atlas identifies molecular subtypes and therapeutic targets","volume":"15","author":"Vijay","year":"2025","journal-title":"Cancer Discov"}],"container-title":["Journal of Surgical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002248042600507X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002248042600507X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T19:13:53Z","timestamp":1793819633000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002248042600507X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":40,"alternative-id":["S002248042600507X"],"URL":"https:\/\/doi.org\/10.1016\/j.jss.2026.07.053","relation":{},"ISSN":["0022-4804"],"issn-type":[{"value":"0022-4804","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RAD51 Predicts Poor Prognosis and Serves as a Therapeutic Target in Intrahepatic Cholangiocarcinoma","name":"articletitle","label":"Article Title"},{"value":"Journal of Surgical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jss.2026.07.053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}